Burundi vs Spain: Access to anti-retroviral drugs, male
Burundi
90.0%
in 2024
Spain
91.0%
in 2022
Burundi rank
13th
Spain rank
12th
Access to anti-retroviral drugs, male over time
- Burundi
- Spain
How they compare
Spain currently reports 91.0% against 90.0% in Burundi, a difference of 1.0%.
Across all 23 years both countries report, Spain has been ahead every year.
Burundi ranks 13th and Spain ranks 12th of 141 countries.
Spain has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burundi | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.8% | 41.7% | 34.9% | Spain |
| 2010s | 45.6% | 73.4% | 27.8% | Spain |
| 2020s | 82.3% | 88.7% | 6.3% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Burundi or Spain?
- Spain, at 91.0% against 90.0% in Burundi as of 2022.
- What is the difference in access to anti-retroviral drugs, male between Burundi and Spain?
- 1.0%, with Spain ahead.
- How many years of comparable data are there for Burundi and Spain?
- 23 years are reported by both, from 2000 to 2022.
- How do Burundi and Spain rank globally for access to anti-retroviral drugs, male?
- Burundi ranks 13th and Spain ranks 12th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.